Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

Biotech stocks took a hit Tuesday, with Vaxcyte, Moderna and Revolution Medicines posting some of the steepest losses.

Biotech firms are gaining major traction in 2026 due to the global pandemic. Take a look at some of the key features of ...

Biotech stocks returned up to 36% in 2025, while longevity investing hit $8.5B in funding. Here’s the data individual ...

Looking for the best biotech penny stocks? The most important innovation of the 1990s was the internet — today, it would be a vaccine for COVID-19. If these times have anything to say about it, the ...

Small-cap stocks Ascentage Pharma, Maze Therapeutics, and Pagaya Technologies show improving fundamentals, strong cash positions, and bullish analyst ratings amid shifting investor interest.

Clinical trials are a key driver of biotech stocks. Every new therapy must pass through a series of testing, Phase 1, Phase 2 ...

Vir Biotechnology develops monoclonal antibodies and RNA-based therapeutics targeting infectious diseases such as COVID-19, hepatitis B, influenza A, and HIV. It generates revenue primarily through ...

I may have beaten this subject to death over the last month or so, but I cannot resist, and will write about it again.However ...

As of Tuesday, October 06, PDS Biotechnology Corporation’s PDSB share price has dipped by 10.83%, which has investors ...

Hong Kong stocks fell as rising oil prices, weak economic data and selling in major technology and biotechnology shares weighed on sentiment. The Hang Seng declined 0.5%, while tech stocks dropped 0.9 ...